Transdermal Peptide TFA

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.

Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.(In Vitro):In the presence of Transdermal Peptide, because of the specific binding of Transdermal Peptide to ATP1B1, cells will upregulate the level of ATP1B1 to maintain function and structure; as a result, the expression of ATP1B1 increases. However, as time goes on, some Transdermal Peptide molecules may be transported into cells by endocytosis; consequently, the expression of ATP1B1 then decreases. The interaction between Transdermal Peptide and ATP1B1 changes not only the expression of ATP1B1, but also the localization of ATP1B1 and then the structure of the epidermal layer. This interaction can be attenuated by inhibitors or competitors, which would result in the reduced delivery of macromolecular drugs across the skin.

——

——

TD 1 (peptide) (TFA)

Others

Other Targets

——

——

——

——

1175.17

C42H65F3N14O18S2

>98% (HPLC)

——

——

Sequence:{Ala}{Cys}{Ser}{Ser}{Ser}{Pro}{Ser}{Lys}{His}{Cys}{Gly} (Disulfide bridge: Cys2-Cys10)

(-20℃)

With Ice Pack

≥ 2 years